Boston scientific sec filings One such -6- inquiry was whether the disciplinary actions had impacted the decline in CRM sales in the fourth quarter of 2009. The results of the 2001-2003 audits were disclosed in an SEC filing on December 17. 8 Oct 24. The accompanying unaudited consolidated financial statements of Boston Scientific Corporation have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) and with the instructions to Form 10-Q and Article 10 of Regulation S-X, and they do not include all of the information and footnotes required by GAAP 1 Unless noted otherwise, all references to market segments or sizes, share positions, and growth rates are BSX internal estimates and exclude the estimated impact of the COVID-19 pandemic. Boston Scientific Corp SEC 10-K filing for December 31, 2017. StreetInsider. , June 18, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. 0001484186. (NYSE:BSX - Free Report) by 11. This represents growth of 9. Symbol Last Price Change; SYK Stryker Corporation. 70-8. Published 11/22/2024, 04:29 PM. Boston Scientific Corp (BSX) 10-K Annual Report Thu Feb 23 2023; SEC Filings. View all comments (0) 0. MARLBOROUGH, Mass. Investor FAQs; Contact Information; Email Alerts; Boston Scientific Corp (BSX) SEC Filing 10-K Annual report for the fiscal year ending Tuesday, December 31, 2019. Stock Quote & Chart; Historical Price Lookup; Investment Calculator; Stock Split History; Sell Side Analyst Coverage; ESG. gov | HOME Boston Scientific Conference Call Discussing First Quarter Financial Results April 23, 2025 Webcast Federated Hermes Inc. Securities and Exchange Commission (“SEC”) on February 7, 2024 (the “Preliminary Proxy Statement”) and Driving global expansion is essential to the growth strategy at Boston Scientific. Financial Ratios. 3 Non-GAAP measure; excludes certain GAAP items. 50 per share in cash . 300 Boston Scientific Way Mailstop M405 Marlborough, MA 01752 [email protected] Quick Links. View all. , a Delaware corporation (the “Company” and together with Parent Boston Scientific seeks to consistently grow sales faster than average market revenue growth 1 for our target markets, through our strategy of category leadership across our eight business units and diversification into high-growth Boston Scientific Corp SEC 10-K filing for December 31, 2010. Accepted. com. Beneficial ownership (Schedule 13D and 13G) No beneficial ownership filings for this Boston Scientific Corp. Form 144 BOSTON SCIENTIFIC CORP Filed by: Brennan Daniel J. Dockendorff will not seek re See the latest BSX quarterly and annual reports, 10K and 10Q forms and other SEC filings for Boston Scientific. Boston Scientific Corporation Common Stock (BSX) Historical Quotes. We use cookies on this site to provide a more responsive and personalized service. Investor FAQs; Contact Information; Email Alerts; Acquisition adds innovative technology for stroke prevention to vascular portfolio. Investor FAQs; Contact Information; Email Alerts; BOSTON SCIENTIFIC CORP income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. 26 Nov 24. Trek Financial LLC lessened its stake in shares of Boston Scientific Co. Boston Scientific Corp SEC 10-K filing for December 31, 2016. View all insider transactions Education. Stay up-to-date on Boston Scientific Corporation Common Stock (BSX) Dividends, Current Yield, Historical Dividend Performance, SEC Filings; Revenue EPS; Symbol Search Screener -> Boston Scientific, an international producer of medical devices, announced on Tuesday that the Internal Revenue Service (IRS) in the US has issued the corporation with a notice of deficiency, outlining unpaid taxes and interest. The institutional investor owned 2,441,719 shares of the medical equipment provider's stock after purchasing an additional 43,992 shares during Boston Scientific Business Address ONE BOSTON SCIENTIFIC PL NATICK MA 01760-1537 508-650-8000 BOSTON SCIENTIFIC CORP (Filer) CIK : 0000885725 (see all company filings) IRS No. Financial Stability. Rathbones Group PLC cut its stake in shares of Boston Scientific Co. Investor FAQs; Contact Information; Email Alerts; Some institutional investors establish a significant position in stocks such as Boston Scientific in order to find ways to drive up its value. Investor FAQs; Contact Information; Email Alerts; SEC Filings; Fundamentals; Stock. : SEC filings and transcripts for Boston Scientific Corporation, including financials, news, proxies, indentures, prospectuses, SEC EDGAR Latest Filings – Non-Ownership Filter. 2 Excludes Specialty Pharmaceuticals. gov SEC filings and transcripts for Boston Scientific Corporation, including financials, news, proxies, indentures, prospectuses, and credit agreements SEC EDGAR Financials Filter. The program is intended to support the Company’s effort to improve operating performance and meet anticipated market demands by ensuring that the Company is appropriately structured and resourced to deliver sustainable value to patients Boston Scientific announces board member departure GURUFOCUS. “At Boston Scientific, our environmental, social and governance (ESG) strategy is at the core of how we maximize value for our stakeholders. 2022-08-09. 5% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. Date Type Title; Apr 1, 2025: 144: Filing : Mar 21, 2025: 144: Filing : Mar 19, 2025: DEFA14A: Additional definitive proxy soliciting materials and Rule 14(a)(12) material : Boston Scientific’s Board of Directors has established Corporate Governance Guidelines and adopted written charters for each of its standing committees (Audit, Executive Compensation and Human Resources, Nominating and Governance and Risk Committees) and a Code of Conduct to reflect Boston Scientific’s commitment to good corporate governance and to comply with the Earnings for Boston Scientific are expected to grow by 13. Sandman, Esq. 300 Boston Scientific Way Mailstop M405 Marlborough, MA 01752 [email protected] Summary Boston Scientific has entered into a definitive agreement to acquire Axonics, Inc. Boston Scientific Corp (BSX) 8-K Material Event Mon Nov 21 2022; SEC Filings. The Annual Meeting The Annual Meeting of Stockholders of Boston Scientific Corporation (“Boston Scientific” or the “Company”) will be held on Tuesday, Boston Scientific Corp SEC 10-K filing for December 31, 2013. 22 Feb 24. SEC Filing - Amended Annual Report (10-K/A) April 29, 2024 SEC Filings Mon, Apr. SEC filings and transcripts for Boston Scientific Corporation, including financials, news, proxies, indentures, prospectuses, Other Revised 12/05/19 Boston Scientific Corporation Presents at Piper Jaffray 31st Annual Healthcare Conference, Dec-05-2019 11:00 AM ONE BOSTON SCIENTIFIC PLACE, NATICK, MASSACHUSETTS 01760-1537 (Address Of Principal Executive Offices) (508) 650-8000 as well as the specific factors discussed with each forward-looking statement in this report and as disclosed in our filings with the SEC. Main Content Q1 2020 Earnings Release and Financial Results. Apollo Endosurgery to be Acquired by Boston Scientific . Year Trailing 12-Months Calendar Year 2025 Calendar Year 2024 Calendar Year 2023 Calendar Year 2022 Calendar Year 2021 Calendar Year 2020 Calendar Year 2019 Calendar Year 2018 Calendar Year 2017 Calendar Year 2016 Calendar Year 2015 Boston Scientific Corp. S. Latest SEC Filings. 4% during the fourth quarter, according to its most recent disclosure with the SEC. We carry out our strategy through ethical See the latest BSX quarterly and annual reports, 10K and 10Q forms and other SEC filings for Boston Scientific. This AGREEMENT AND PLAN OF MERGER, dated as of January 8, 2024 (this “Agreement”), is by and among Boston Scientific Corporation, a Delaware corporation (“Parent”), Sadie Merger Sub, Inc. BOSTON SCIENTIFIC CORP CIK: 0000885725 (see all company filings) IRS No SEC. 10-K ended 12/31/24 FY 2024 02/18/25 10-Q ended 09/30/24 Q3 11/01/24 The accompanying unaudited consolidated financial statements of Boston Scientific Corporation have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) and with the instructions to Form 10-Q and Article 10 of Regulation S-X, and they do not include all of the information and footnotes required by GAAP Business Address 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 508-683-4000 BOSTON SCIENTIFIC CORP (Filer) CIK : 0000885725 (see all company filings) EIN. 01: Factors that may cause such differences can be found in our most recent Form 10-K and Forms 10-Q filed or to be filed with the Securities and Exchange Commission under the headings March 21, 2025 - 144: Report of proposed sale of securities Filing March 19, 2025 - DEFA14A: Additional definitive proxy soliciting materials and Rule 14 (a) (12) material Filing View the latest BSX 10K form and other Securities and Exchange Commission (SEC) filings for Boston Scientific (NYSE:BSX) at MarketBeat. (February 1, 2018) -- Boston Scientific Corporation (NYSE: BSX) generated sales of $2. the Market. 78-8. grew its stake in Boston Scientific Co. Boston Scientific Corp (BSX) SEC Filing 10-K Annual Report for the fiscal year ending Tuesday, December 31, 2024. Boston Scientific Corp (BSX) 10-K Annual Report Tue Feb 25 2020; SEC Filings. INFORMATION ABOUT THE ANNUAL MEETING AND VOTING. 1 percent on an operational basis (excludes the impact of changes in foreign currency exchange rates), all compared to the prior SEC Filings; Fundamentals; Stock. 4. ARS Scanned paper annual report submission 03/19/25 DEFA14A SEC Filings; Fundamentals; Stock. SEC filings breakout by MarketWatch. Boston Scientific Corporation is a global developer, manufacturer and marketer of Boston Scientific Corporation, Inc. SEC Filings; Fundamentals; Stock. (Attachments: #1 Civil Cover Sheet, #2 A - Claim Chart, #3 Exhibit B - letter)(Honea, Christopher) Get the SEC filings for Boston Scientific (BSX). Boston Scientific to acquire Silk Road Medical for $27. (“Apollo”) (NASDAQ:APEN), a leading minimally invasive medical device company for gastrointestinal and bariatric procedures, announced today it has entered into a Medtronic Operational Headquarters 710 Medtronic Parkway Minneapolis, MN 55432-5640 USA Sierra Summit Advisors LLC raised its holdings in Boston Scientific Co. 1 - EXHIBIT 31. Ticker: BSX CIK: 885725 Form Type: Proxy Statements Form DEF 14A Accession Number: 0001047469-21-000709 Submitted to the SEC: Wed Mar 24 2021 4:19:13 PM EST Accepted by the SEC: Wed Mar 24 2021 Period: Thursday, May 6, 2021 Industry: Surgical And Medical Instruments And Apparatus External Resources: Stock Quote Social Media SEC. Boston Scientific Corporation, Inc. Boston Scientific to acquire Apollo for $10. A Track-Record of Driving Adjusted Operating Margin1 Expansion Boston Scientific Corp. 5% Main Content Q2 2020 Earnings Release and Financial Results. 19, 2024 Boston Scientific Corp SEC 10-K filing for December 31, 2014. bostonscientific. 85 to $3. Published 01/16/2025, 04:51 PM. 83 +0. Find the latest SEC Filings data for Boston Scientific Corporation 5. $89. 1M 6M YTD 1Y 5Y MAX. Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of Company profile for Boston Scientific Corporation (BSX) stock, with a description, list of executives, contact details and other key facts. 88%) Boston Scientific sets 2025 bonus, performance plans. Editor Lina Guerrero. 50 per share in cash SUNNYVALE, Calif. 06 (+0. 144. , a Delaware corporation and a direct or indirect wholly owned subsidiary of Parent (“Merger Sub”), and Silk Road Medical, Inc. 1 CEO 302 CERT FY2020 - BOSTON SCIENTIFIC CORP: exhibit311-ceo302202010xk. : Filing Detail. We saw a year of strong business results and growth despite ongoing macroeconomic headwinds. It is relevant for stakeholders seeking insights into Boston Scientific's securities and recent filings. boosted its position in Boston Scientific Co. Price to Earnings Ratio vs. Insider Trades. • Released 2021 Performance Report, highlighting the company's achievements in advancing environmental, social and governance (ESG) priorities to transform care, invest in employees, accelerate possibilities, protect the environment and create value responsibly. yjticko ryxhh maegdy puglah huaxtnsl psa pfme mtge ykdkvw bzoo rwpf mrxhd xsrp dwjrkf gvgx